Bill

Bill > AB1088


CA AB1088

CA AB1088
Public health: kratom.


summary

Introduced
02/20/2025
In Committee
06/10/2026
Crossed Over
06/02/2025
Passed
Dead

Introduced Session

2025-2026 Regular Session

Bill Summary

An act to add Article 16 (commencing with Section 111224.8) to Chapter 5 of Part 5 of Division 104 of the Health and Safety Code, relating to public health, and making an appropriation therefor.

AI Summary

This bill establishes a comprehensive regulatory framework for kratom products in California, treating them similarly to food and drug products under the Sherman Food, Drug, and Cosmetic Law. Key provisions include defining "kratom product" to encompass kratom leaf, extract, and specific alkaloids like 7-hydroxymitragynine (7-OH), and requiring processors to register with the State Department of Public Health and annually register each kratom product, including laboratory certification of compliance. The bill mandates specific labeling requirements, including a warning about illegality for those under 21 and prohibiting health claims, and sets limits on the amounts of mitragynine and 7-hydroxymitragynine per package. It prohibits the sale of kratom products to individuals under 21, and also restricts sales at locations or online platforms accessible to minors, and prohibits products with "child-attractive flavors" or packaging that appeals to children. Furthermore, a 15% tax will be imposed on the purchase of kratom products, with the revenue directed to a newly created Kratom Products Public Health and Safety Fund, which will then allocate funds to various entities including medical education, law enforcement support, and public health programs. The bill also allows the department to deny, suspend, or revoke registrations for violations and creates a state-mandated local program by expanding the scope of criminal offenses.

Committee Categories

Agriculture and Natural Resources, Budget and Finance, Health and Social Services

Sponsors (1)

Last Action

In committee: Set, first hearing. Hearing canceled at the request of author. (on 06/17/2026)

Bill Topics

Health
  • ‐ Drug Abuse, Treatment, and Education
  • ‐ Regulation of Drug Industry and Pharmacies
Macroeconomics
  • ‐ Taxation, Tax Policy, and Tax Reform

bill text


bill summary

Loading...

bill summary

Loading...
Loading...